Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gini Fleming
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
108 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Stanford Cancer Institute
Palo Alto, California, United States
- University of California San Diego
San Diego, California, United States
- Colorado Gynecologic Oncology Group
Aurora, Colorado, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- John B Amos Cancer Center
Columbus, Georgia, United States
- Memorial University Medical Center
Savannah, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Menorah Medical Center
Overland Park, Kansas, United States
- Radiation Oncology Practice Corporation Southwest
Overland Park, Kansas, United States
- Saint Luke'S South Hospital
Overland Park, Kansas, United States
- Shawnee Mission Medical Center-Kccc
Shawnee Mission, Kansas, United States
- Medstar Franklin Square Medical Center/weinberg Cancer Institute
Baltimore, Maryland, United States
- Sinai Hospital of Baltimore
Baltimore, Maryland, United States
- Union Hospital of Cecil County
Elkton, Maryland, United States
- University of Massachusetts Medical School
Worcester, Massachusetts, United States
- University of Massachusetts Memorial Health Care
Worcester, Massachusetts, United States
- Michigan Cancer Research Consortium Ncorp
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Bronson Battle Creek
Battle Creek, Michigan, United States
- Spectrum Health Big Rapids Hospital
Big Rapids, Michigan, United States
- Beaumont Hospital-Dearborn
Dearborn, Michigan, United States
- Saint John Hospital and Medical Center
Detroit, Michigan, United States
- Green Bay Oncology - Escanaba
Escanaba, Michigan, United States
- Genesys Regional Medical Center-West Flint Campus
Flint, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Cancer Research Consortium of West Michigan Ncorp
Grand Rapids, Michigan, United States
- Mercy Health Saint Mary'S
Grand Rapids, Michigan, United States
- Spectrum Health at Butterworth Campus
Grand Rapids, Michigan, United States
- Green Bay Oncology - Iron Mountain
Iron Mountain, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2008
- Primary completion
- 28 Feb 2017
- Completion
- 28 Feb 2017
- Last update posted
- 23 Jul 2019
- Registered enrollment
- 73
- Registry id
- NCT00729586
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.